Hosted on MSN11mon
Reasons Why Danaher (DHR) Should be in Your Portfolio NowIn December 2023, Danaher acquired Abcam plc, a global supplier of protein consumables, for $5.7 billion. The inclusion of Abcam's strong innovation capabilities and robust product line are ...
Abcam is a life sciences company specialized in the provision of customizable, advanced antibody-discovery solutions for research, diagnostic and therapeutic applications. Many of the organization ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results